Pfizer Total Liabilities 2010-2024 | PFE

Prices Revenue & Profit Assets & Liabilities Margins Price Ratios

Total Assets Cash on Hand Long Term Debt Total Liabilities

Pfizer total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Pfizer total liabilities for the quarter ending June 30, 2024 were $128.218B, a 6.07% increase year-over-year.
Pfizer total liabilities for 2023 were $137.213B, a 35.47% increase from 2022.
Pfizer total liabilities for 2022 were $101.288B, a 2.62% decline from 2021.
Pfizer total liabilities for 2021 were $104.013B, a 14.61% increase from 2020.

Prices Revenue & Profit Assets & Liabilities Margins Price Ratios

Total Assets Cash on Hand Long Term Debt Total Liabilities

Pfizer total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Pfizer total liabilities for the quarter ending June 30, 2024 were $128.218B, a 6.07% increase year-over-year.
Pfizer total liabilities for 2023 were $137.213B, a 35.47% increase from 2022.
Pfizer total liabilities for 2022 were $101.288B, a 2.62% decline from 2021.
Pfizer total liabilities for 2021 were $104.013B, a 14.61% increase from 2020.